
Chemomab Therapeutics Ltd.
USD1.69
+0.07 (+4.32%)
CEO
Adi Mor George
IPO Date
2019-02-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IL
Open
$1.71
Prev. Close
$1.62
Day Low
$1.66
Day High
$1.74
52W Low
$1.35
52W High
$4.92
Market Cap
$0.01B
Volume
0.01M
| 15 Nov 2024 |
| Oppenheimer |
| Outperform |
| Outperform |
| maintain |
| 6 May 2024 | Oppenheimer | Perform | Outperform | upgrade |
| 8 Mar 2024 | Oppenheimer | Perform | Perform | maintain |
| 7 Jun 2023 | Oppenheimer | Outperform | Perform | downgrade |
| 18 Apr 2023 | Oppenheimer | Outperform | Outperform | maintain |
| 10 Mar 2022 | Oppenheimer | Outperform | Outperform | maintain |
| 7 Dec 2021 | Aegis Capital | Buy | Buy | maintain |